NORADRENALINE SYNTHESIS AFTER SYMPATHETIC-NERVE ACTIVATION IN RAT ATRIA AND ITS DEPENDENCE ON CALCIUM BUT NOT CAM KINASE-II AND PROTEIN-KINASE-A OR PROTEIN-KINASE-C
P. Kotsonis et al., NORADRENALINE SYNTHESIS AFTER SYMPATHETIC-NERVE ACTIVATION IN RAT ATRIA AND ITS DEPENDENCE ON CALCIUM BUT NOT CAM KINASE-II AND PROTEIN-KINASE-A OR PROTEIN-KINASE-C, British Journal of Pharmacology, 119(8), 1996, pp. 1605-1613
1 The biosynthesis of noradrenaline following sympathetic nerve activa
tion was investigated in rat atria. In particular the time course of n
oradrenaline synthesis changes, the relationship of changes in synthes
is to transmitter release and the possible roles of second messengers
and protein kinases were examined. 2 Rat atria incubated with the prec
ursor [H-3]-tyrosine synthesized [H-3]-noradrenaline, Synthesis was en
hanced following pulsatile electrical field stimulation (3 Hz for 5 mi
n) with the bulk of the increase occurring in the first 45 min after t
he commencement of electrical stimulation. In separate experiments rat
atria were pre-incubated with [H-3]-noradrenaline and the radioactive
outflow in response to electrical field stimulation (3 Hz for 5 min)
was taken as an index of noradrenaline release. 3 Stimulation-induced
(S-I) noradrenaline synthesis was significantly correlated to S-I nora
drenaline release for a variety of procedures which modulate noradrena
line release by mechanisms altering Ca2+ entry into the neurone (r(2)=
0.99): those which decreased release: tetrodotoxin (0.3 mu M), Ca2+-fr
ee medium, lowering the frequency of nerve activation to 1 Hz, and tho
se which increased release, tetraethylammonium (0.3 mM), phentolamine
(1 mu M) and the combination of phentolamine (1 mu M) and adenosine (1
0 mu M). On the strength of this relationship we suggest that Ca2+ ent
ry is a determining factor in S-I synthesis changes rather than the am
ount of noradrenaline released. Indeed the reduction in noradrenaline
release with the calmodulin-dependent protein (CAM) kinase II inhibito
r KN-62 (10 mu M) which acts subsequent to Ca2+ entry, did not affect
S-I synthesis. 4 The cell permeable cyclic AMP analogue, 8-bromoadenos
ine 3',5'-monophosphate (BrcAMP, 90 and 270 mu M), dose-dependently in
creased basal [H-3]-noradrenaline synthesis in unstimulated rat atria.
This effect was antagonized by the selective protein kinase A (PKA) a
ntagonist, Rp-8-chloroadenosine 3', 5-'cyclic monophosphorothioate (RC
lcAMPS, 300 mu M), suggesting that PKA activation enhances basal norad
renaline biosynthesis in sympathetic nerve terminals. 5 The protein ki
nase inhibitors, KN-62 (CAM kinase II, 10 mu M), RClcAMPS (PKA, 300 mu
M), polymyxin B (protein kinase C (PKC), 21 mu M) and staurosporine (
PKC, PKA and CAM kinase II, 0.1 mu M) did not affect S-I synthesis, al
though KN-62, polymyxin B and staurosporine decreased S-I release. We
conclude that S-I synthesis is triggered by Ca2+ entering the neurone
but that the signalling pathway does not involve classical protein kin
ases and appears distinct from the steps involved in transmitter relea
se.